Hill-Rom stock: buy or sell?
August 23rd, 2019
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Should I buy Hill-Rom stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Hill-Rom stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Hill-Rom stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we collected 6 ratings published for HRC stock in the last month. The general sentiment of these ratings is bullish for HRC stock, with 3 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-6||Needham & Company LLC||n/a||Buy|
|2019-4-15||Barclays||Equal Weight||Equal Weight|
|2019-3-11||Needham & Company LLC||n/a||Buy|
|2019-1-2||Morgan Stanley||Equal Weight||Equal Weight|
Hill-Rom stock analysis
Hill-Rom decreased a fatal -1.36% and closed at $104.26.
Shares of Hill-Rom closed today at $104.26 and decreased a fatal -1.36%. On August 1st, HRC hit new all time highs, pushing higher previous ATH of $108.47 recorded on March. New ATHs are usual entry points for many trading setups as there aren't higher resistences. Since last June when HRC stock price broke up the SMA200d line, it gained $8.30 (8.65%). Since SMA50d and SMA100d crossed up on July 24th, HRC price slid a -1.92%.
Hill-Rom shares decreased -0.94% this week, ending at $104.26.
Observing the weekly chart, price is in a simple uptrend, tested $99.20 level and now climbing back aiming its last top at $109.18. Not so far away is the last price record Hill-Rom marked late July. Early June HRC price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since late July when SMA10w and SMA20w crossed up, HRC price slipped $-0.84 per share (-0.80%).
Hill-Rom stock price history
Hill-Rom stock historical price chart
HRC stock reached all-time highs on Aug 1st with a price of $109.18.
Hill-Rom stock price target is $114.70Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 6 price forecasts for HRC stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-6||Needham & Company LLC||Reiterates||n/a||$125.00||-|
|2019-3-11||Needham & Company LLC||Reiterates||n/a||$116.00||-|
|2019-1-2||Morgan Stanley||Lowers Target||$100.00||$98.00||-2%|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince April, when Hill-Rom presented its last earnings report, it soared a shining 8.53%. As soon as we get its actual EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Hill-Rom annual sales raised a decent 3.80% to $2,848.00 million USD from $2,743.70 marked in 2017. When comparing 2018 vs 2017, aligned with this, profit margin (that is, the net income divided by revenues) stepped up a 3.99% to 8.86%. To have an up to date picture of the financial situation of Hill-Rom, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Hill-Rom TTM sales up to March 2019 were $2,865.50 and income was $227.30 M dollars. When comparing this TTM figures with the last reported annuality, we can esteem Hill-Rom business evolution since September 2018: Annual turnover up to March, compared to lastest yearly report, stayed stable a slightly fine 0.61%. Regarding profit margin, Hill-Rom remained stable -0.93% to 8.86%
|2013||$1,720 M||-||$105 M6.1%||-|
|2014||$1,686 M||-1.97%||$61 M3.6%||-42.29%|
|2015||$1,988 M||17.92%||$48 M2.4%||-21.29%|
|2016||$2,655 M||33.55%||$124 M4.7%||160.17%|
|2017||$2,744 M||3.33%||$134 M4.9%||7.66%|
|2018||$2,848 M||3.80%||$252 M8.9%||88.92%|
|TTM||$2,866 M||0.61%||$227 M7.9%||-9.94%|
Quarterly financial resultsHill-Rom reported $714.20 M in revenues for 2019-Q1, a 4.49% improvement compared to previous quarter. Reported quarter income marked $49.50 million with a profit margin of 6.93%. Profit margin stayed constant a 0.76% compared to previous quarter when profit margin was 6.17%. When comparing sales to same quarter last year, Hill-Rom sales marked a neutral movement and remained steady a 0.52%.
|2017-Q2||$689 M||-||$6 M0.9%||-|
|2017-Q3||$738 M||7.14%||$69 M9.4%||1,056.67%|
|2017-Q4||$670 M||-9.29%||$88 M13.2%||27.23%|
|2018-Q1||$711 M||6.09%||$29 M4.0%||-67.72%|
|2018-Q2||$709 M||-0.27%||$45 M6.4%||58.60%|
|2018-Q3||$759 M||7.14%||$90 M11.9%||100.00%|
|2018-Q4||$684 M||-9.97%||$42 M6.2%||-53.32%|
|2019-Q1||$714 M||4.49%||$50 M6.9%||17.30%|
Hill-Rom ownershipWhen you are planning to buy a stock, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Hill-Rom, 0.15% of all outstanding shares are owned by its staff.
Bearish positions for HRC stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$6.9 B||$13.0 B||$44.8 M||$71.5 B||$174.2 M|
|Total shares||66.7 M||298.1 M||8.4 M||8,730.0 M||33.8 M|
|Float shares||66.6 M||296.8 M||6.8 M||8,720.0 M||32.8 M|
|- Institutional holdings (%)||86.3%||92.4%||25.9%||58.6%||124.2%|
|- Insider holdings (%)||0.1%||0.3%||18.5%||0.2%||3.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, August 23rd, 2019|
|Day range||$104.01 - $107.65|
|Average true range||$2.17|
|50d mov avg||$105.31|
|100d mov avg||$102.64|
|200d mov avg||$100.02|
Hill-Rom performanceTo better understand Hill-Rom performance you must compare its gains with other related stocks in same sector or industry. We picked Cardinal Health, Electromed, General Electric, Invacare, Stryker and Zimmer Biomet as the bechmarking frame for Hill-Rom stock.